Cerity Partners OCIO’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,585
Closed -$686K 400
2020
Q4
$686K Sell
4,585
-6
-0.1% -$847 0.03% 214
2020
Q3
$607K Buy
4,591
+139
+3% +$18.2K 0.03% 206
2020
Q2
$516K Sell
4,452
-1
-0% -$115 0.02% 223
2020
Q1
$437K Buy
4,453
+322
+8% +$42.2K 0.02% 210
2019
Q4
$627K Sell
4,131
-3,905
-49% -$539K 0.03% 204
2019
Q3
$1.07M Buy
8,036
+125
+2% +$16.1K 0.06% 143
2019
Q2
$904K Buy
7,911
+228
+3% +$26.7K 0.05% 152
2019
Q1
$953K Buy
7,683
+690
+10% +$78.4K 0.05% 135
2018
Q4
$704K Buy
6,993
+302
+5% +$34K 0.05% 161
2018
Q3
$854K Sell
6,691
-151
-2% -$18K 0.05% 144
2018
Q2
$740K Sell
6,842
-150
-2% -$16.3K 0.05% 145
2018
Q1
$740K Buy
+6,992
New +$812K 0.05% 142

Other funds holding ZBH

Cerity Partners OCIO's ZBH Position: Q1 2021 in Review

Cerity Partners OCIO sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 4,585 shares — an estimated $686K sold.

Cerity Partners OCIO first reported a position in ZBH in Q1 2018 and held it in 12 quarters. The position peaked at $1.07M in Q3 2019. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Cerity Partners OCIO reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Cerity Partners OCIO sold 4,585 Zimmer Biomet shares in Q1 2021, an estimated $686K.
  • Cerity Partners OCIO first reported a position in Zimmer Biomet in Q1 2018 and held it in 12 quarters.
  • Cerity Partners OCIO's Zimmer Biomet position peaked at $1.07M in Q3 2019.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Cerity Partners OCIO's 13F filing for Q1 2021, filed 6 May 2021.